Nathalie Clerget has more than 16 years’ experience working in the field of clinical operations at both CRO and corporate level in the areas of inflammatory bowel disease and ophthalmology. She has significant expertise in clinical trial management and associated regulatory aspects, mainly in the early development phase of trials.
Before joining Promethera Nathalie was Senior Director of Clinical Operations at TxCell where she was part of project level decision making, managing operationally complex studies in autologous cell-based therapies in autoimmune diseases and leading all operational aspects of clinical trials. She started her career at the CRO IrisPharma, where she held several functions such as Quality Assurance and Regulatory Manager and Clinical Project Manager.
Nathalie holds a PhD in Molecular and Cell
Biology from the University of Paris V.